Docusign Inc. $DOCU Stake Reduced by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. cut its stake in Docusign Inc. (NASDAQ:DOCU) by 42.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 214,345 shares of the company’s stock after selling 158,142 shares during the period. Robeco Institutional Asset Management B.V. owned 0.11% of Docusign worth $15,452,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of DOCU. Asset Management One Co. Ltd. boosted its stake in Docusign by 1.1% during the 3rd quarter. Asset Management One Co. Ltd. now owns 77,697 shares of the company’s stock valued at $5,601,000 after purchasing an additional 883 shares during the period. Gateway Investment Advisers LLC bought a new stake in shares of Docusign during the third quarter valued at approximately $821,000. GraniteShares Advisors LLC boosted its position in shares of Docusign by 13.4% during the third quarter. GraniteShares Advisors LLC now owns 5,979 shares of the company’s stock worth $431,000 after buying an additional 705 shares during the period. SJS Investment Consulting Inc. boosted its position in shares of Docusign by 5,318.2% during the third quarter. SJS Investment Consulting Inc. now owns 596 shares of the company’s stock worth $43,000 after buying an additional 585 shares during the period. Finally, Cascade Financial Partners LLC bought a new position in Docusign in the 3rd quarter worth approximately $303,000. Institutional investors and hedge funds own 77.64% of the company’s stock.

Docusign Stock Performance

NASDAQ DOCU opened at $69.80 on Friday. Docusign Inc. has a 1 year low of $63.41 and a 1 year high of $99.30. The business’s fifty day moving average is $68.52 and its two-hundred day moving average is $72.97. The stock has a market capitalization of $13.98 billion, a P/E ratio of 48.81, a P/E/G ratio of 3.43 and a beta of 0.99.

Insiders Place Their Bets

In other news, insider James P. Shaughnessy sold 12,000 shares of Docusign stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $67.03, for a total value of $804,360.00. Following the transaction, the insider directly owned 54,550 shares of the company’s stock, valued at $3,656,486.50. This trade represents a 18.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CRO Paula Hansen sold 6,000 shares of the company’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $67.05, for a total transaction of $402,300.00. Following the completion of the sale, the executive owned 68,970 shares of the company’s stock, valued at approximately $4,624,438.50. This trade represents a 8.00% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 45,542 shares of company stock worth $3,092,260 over the last three months. Company insiders own 1.01% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. BTIG Research started coverage on Docusign in a research note on Tuesday, December 16th. They set a “buy” rating and a $88.00 target price on the stock. Needham & Company LLC restated a “hold” rating on shares of Docusign in a research note on Wednesday, December 17th. JPMorgan Chase & Co. reduced their price objective on shares of Docusign from $80.00 to $78.00 and set a “neutral” rating for the company in a report on Friday, December 5th. Wedbush lowered their target price on shares of Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a research note on Friday, December 5th. Finally, JMP Securities reaffirmed a “market outperform” rating and issued a $124.00 price target on shares of Docusign in a research note on Friday, October 3rd. Six analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $85.13.

Docusign Profile

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.